These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2498637)

  • 1. Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
    Johnson RA; Yeung SM; Stübner D; Bushfield M; Shoshani I
    Mol Pharmacol; 1989 May; 35(5):681-8. PubMed ID: 2498637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
    Bushfield M; Shoshani I; Johnson RA
    Mol Pharmacol; 1990 Dec; 38(6):848-53. PubMed ID: 2174505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ammonium ions enhance proteolytic activation of adenylate cyclase and decrease its sensitivity to inhibition by "P"-site agonists.
    Yeung SM; Shoshani I; Stübner D; Johnson RA
    Arch Biochem Biophys; 1989 Jun; 271(2):332-45. PubMed ID: 2658808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of adenylate cyclase attenuates adenosine receptor-mediated relaxation in coronary artery.
    Sabouni MH; Cushing DJ; Makujina SR; Mustafa SJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):508-12. PubMed ID: 1658301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
    Laurenza A; Khandelwal Y; De Souza NJ; Rupp RH; Metzger H; Seamon KB
    Mol Pharmacol; 1987 Jul; 32(1):133-9. PubMed ID: 3600614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of rat heart membrane adenylate cyclase by magnesium and manganese.
    Steinberg SF; Chow YK; Bilezikian JP
    J Pharmacol Exp Ther; 1986 Jun; 237(3):764-72. PubMed ID: 3086539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adenylyl cyclase activity in brain membrane fractions by arachidonic acid and related unsaturated fatty acids.
    Nakamura J; Okamura N; Usuki S; Bannai S
    Arch Biochem Biophys; 2001 May; 389(1):68-76. PubMed ID: 11370673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of "P"-site-mediated inhibition of adenylyl cyclase and the requirements for substrate.
    Johnson RA; Shoshani I
    J Biol Chem; 1990 Jul; 265(20):11595-600. PubMed ID: 2365688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of adenylate cyclase activity in cultured bovine pulmonary arterial endothelial cells. Effects of adenosine and derivatives.
    Legrand AB; Narayanan TK; Ryan US; Aronstam RS; Catravas JD
    Biochem Pharmacol; 1989 Feb; 38(3):423-30. PubMed ID: 2465005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between muscarinic receptor-mediated inhibition of adenylate cyclase and autoreceptor inhibition of [3H] acetylcholine release in rat hippocampus.
    Vickroy TW; Cadman ED
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1039-44. PubMed ID: 2557410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Xenopus oocyte adenylate cyclase by progesterone: a novel mechanism of action.
    Sadler SE; Maller JL
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():179-94. PubMed ID: 3159186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system.
    Bode DC; Molinoff PB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1040-7. PubMed ID: 2843625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the catalytic component of adenylate cyclase. Potentiative interaction of stimulatory ligands and 2',5'-dideoxyadenosine.
    Florio VA; Ross EM
    Mol Pharmacol; 1983 Sep; 24(2):195-202. PubMed ID: 6310361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
    Siegl AM; Daly JW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for two different stimulatory adenylate cyclase coupling mechanisms in rat renal papilla.
    Woodcock EA
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):301-16. PubMed ID: 2947938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and "P"-site agonists.
    Johnson RA; Shoshani I
    J Biol Chem; 1990 Nov; 265(31):19035-9. PubMed ID: 2121733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.
    Laurenza A; Morris D; Seamon KB
    Mol Pharmacol; 1990 Jan; 37(1):69-74. PubMed ID: 2153911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization in rat parotid to beta-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activity.
    Harper JF
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):167-76. PubMed ID: 2876014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.